323 related articles for article (PubMed ID: 26285059)
1. Antipsychotic drugs attenuate aberrant DNA methylation of DTNBP1 (dysbindin) promoter in saliva and post-mortem brain of patients with schizophrenia and Psychotic bipolar disorder.
Abdolmaleky HM; Pajouhanfar S; Faghankhani M; Joghataei MT; Mostafavi A; Thiagalingam S
Am J Med Genet B Neuropsychiatr Genet; 2015 Dec; 168(8):687-96. PubMed ID: 26285059
[TBL] [Abstract][Full Text] [Related]
2. DNA hypermethylation of serotonin transporter gene promoter in drug naïve patients with schizophrenia.
Abdolmaleky HM; Nohesara S; Ghadirivasfi M; Lambert AW; Ahmadkhaniha H; Ozturk S; Wong CK; Shafa R; Mostafavi A; Thiagalingam S
Schizophr Res; 2014 Feb; 152(2-3):373-80. PubMed ID: 24411530
[TBL] [Abstract][Full Text] [Related]
3. Hypomethylation of the serotonin receptor type-2A Gene (HTR2A) at T102C polymorphic site in DNA derived from the saliva of patients with schizophrenia and bipolar disorder.
Ghadirivasfi M; Nohesara S; Ahmadkhaniha HR; Eskandari MR; Mostafavi S; Thiagalingam S; Abdolmaleky HM
Am J Med Genet B Neuropsychiatr Genet; 2011 Jul; 156B(5):536-45. PubMed ID: 21598376
[TBL] [Abstract][Full Text] [Related]
4. DNA hypomethylation of MB-COMT promoter in the DNA derived from saliva in schizophrenia and bipolar disorder.
Nohesara S; Ghadirivasfi M; Mostafavi S; Eskandari MR; Ahmadkhaniha H; Thiagalingam S; Abdolmaleky HM
J Psychiatr Res; 2011 Nov; 45(11):1432-8. PubMed ID: 21820670
[TBL] [Abstract][Full Text] [Related]
5. Aberrant transcriptomes and DNA methylomes define pathways that drive pathogenesis and loss of brain laterality/asymmetry in schizophrenia and bipolar disorder.
Abdolmaleky HM; Gower AC; Wong CK; Cox JW; Zhang X; Thiagalingam A; Shafa R; Sivaraman V; Zhou JR; Thiagalingam S
Am J Med Genet B Neuropsychiatr Genet; 2019 Mar; 180(2):138-149. PubMed ID: 30468562
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of the reelin (RELN) promoter in the brain of schizophrenic patients: a preliminary report.
Abdolmaleky HM; Cheng KH; Russo A; Smith CL; Faraone SV; Wilcox M; Shafa R; Glatt SJ; Nguyen G; Ponte JF; Thiagalingam S; Tsuang MT
Am J Med Genet B Neuropsychiatr Genet; 2005 Apr; 134B(1):60-6. PubMed ID: 15717292
[TBL] [Abstract][Full Text] [Related]
7. Dysbindin (DTNBP1) variants are associated with hallucinations in schizophrenia.
Cheah SY; Lawford BR; Young RM; Morris CP; Voisey J
Eur Psychiatry; 2015 Jun; 30(4):486-91. PubMed ID: 25697573
[TBL] [Abstract][Full Text] [Related]
8. Association of the dystrobrevin binding protein 1 gene (DTNBP1) in a bipolar case-control study (BACCS).
Gaysina D; Cohen-Woods S; Chow PC; Martucci L; Schosser A; Ball HA; Tozzi F; Perry J; Muglia P; Craig IW; McGuffin P; Farmer A
Am J Med Genet B Neuropsychiatr Genet; 2009 Sep; 150B(6):836-44. PubMed ID: 19089808
[TBL] [Abstract][Full Text] [Related]
9. Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder.
Carrard A; Salzmann A; Malafosse A; Karege F
J Affect Disord; 2011 Aug; 132(3):450-3. PubMed ID: 21453976
[TBL] [Abstract][Full Text] [Related]
10. Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder.
Abdolmaleky HM; Cheng KH; Faraone SV; Wilcox M; Glatt SJ; Gao F; Smith CL; Shafa R; Aeali B; Carnevale J; Pan H; Papageorgis P; Ponte JF; Sivaraman V; Tsuang MT; Thiagalingam S
Hum Mol Genet; 2006 Nov; 15(21):3132-45. PubMed ID: 16984965
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder.
Abdolmaleky HM; Yaqubi S; Papageorgis P; Lambert AW; Ozturk S; Sivaraman V; Thiagalingam S
Schizophr Res; 2011 Jul; 129(2-3):183-90. PubMed ID: 21550210
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation analyses of the candidate genes identified by a methylome-wide association study revealed common epigenetic alterations in schizophrenia and bipolar disorder.
Sugawara H; Murata Y; Ikegame T; Sawamura R; Shimanaga S; Takeoka Y; Saito T; Ikeda M; Yoshikawa A; Nishimura F; Kawamura Y; Kakiuchi C; Sasaki T; Iwata N; Hashimoto M; Kasai K; Kato T; Bundo M; Iwamoto K
Psychiatry Clin Neurosci; 2018 Apr; 72(4):245-254. PubMed ID: 29430824
[TBL] [Abstract][Full Text] [Related]
13. A reappraisal of the association between Dysbindin (DTNBP1) and schizophrenia in a large combined case-control and family-based sample of German ancestry.
Strohmaier J; Frank J; Wendland JR; Schumacher J; Jamra RA; Treutlein J; Nieratschker V; Breuer R; Mattheisen M; Herms S; Mühleisen TW; Maier W; Nöthen MM; Cichon S; Rietschel M; Schulze TG
Schizophr Res; 2010 May; 118(1-3):98-105. PubMed ID: 20083391
[TBL] [Abstract][Full Text] [Related]
14. Promoter Activity-Based Case-Control Association Study on SLC6A4 Highlighting Hypermethylation and Altered Amygdala Volume in Male Patients With Schizophrenia.
Ikegame T; Bundo M; Okada N; Murata Y; Koike S; Sugawara H; Saito T; Ikeda M; Owada K; Fukunaga M; Yamashita F; Koshiyama D; Natsubori T; Iwashiro N; Asai T; Yoshikawa A; Nishimura F; Kawamura Y; Ishigooka J; Kakiuchi C; Sasaki T; Abe O; Hashimoto R; Iwata N; Yamasue H; Kato T; Kasai K; Iwamoto K
Schizophr Bull; 2020 Dec; 46(6):1577-1586. PubMed ID: 32556264
[TBL] [Abstract][Full Text] [Related]
15. Altered DNA methylation of the
Li S; Zong L; Hou Y; Zhang W; Zhou L; Yang Q; Wang L; Jiang W; Li Q; Huang X; Ning Y; Wen Z; Zhao C
Epigenomics; 2019 May; 11(6):581-586. PubMed ID: 31066577
[No Abstract] [Full Text] [Related]
16. Analysis of HapMap tag-SNPs in dysbindin (DTNBP1) reveals evidence of consistent association with schizophrenia.
Voisey J; Swagell CD; Hughes IP; Lawford BR; Young RM; Morris CP
Eur Psychiatry; 2010 Oct; 25(6):314-9. PubMed ID: 20615671
[TBL] [Abstract][Full Text] [Related]
17. Effect of 5-haplotype of dysbindin gene (DTNBP1) polymorphisms for the susceptibility to bipolar I disorder.
Pae CU; Serretti A; Mandelli L; Yu HS; Patkar AA; Lee CU; Lee SJ; Jun TY; Lee C; Paik IH; Kim JJ
Am J Med Genet B Neuropsychiatr Genet; 2007 Jul; 144B(5):701-3. PubMed ID: 17192893
[TBL] [Abstract][Full Text] [Related]
18. Quantitative detection of methylated SOCS-1 in schizophrenia and bipolar disorder considering SOCS-1 -1478CA/del polymorphism and clinical parameters.
Aytac HM; Pehlivan S; Pehlivan M; Oyaci Y
Ir J Med Sci; 2023 Apr; 192(2):775-783. PubMed ID: 35593996
[TBL] [Abstract][Full Text] [Related]
19. Dysbindin (DTNBP1)--a role in psychotic depression?
Domschke K; Lawford B; Young R; Voisey J; Morris CP; Roehrs T; Hohoff C; Birosova E; Arolt V; Baune BT
J Psychiatr Res; 2011 May; 45(5):588-95. PubMed ID: 20951386
[TBL] [Abstract][Full Text] [Related]
20. Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDII.
D'Addario C; Dell'Osso B; Palazzo MC; Benatti B; Lietti L; Cattaneo E; Galimberti D; Fenoglio C; Cortini F; Scarpini E; Arosio B; Di Francesco A; Di Benedetto M; Romualdi P; Candeletti S; Mari D; Bergamaschini L; Bresolin N; Maccarrone M; Altamura AC
Neuropsychopharmacology; 2012 Jun; 37(7):1647-55. PubMed ID: 22353757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
